Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Aguado

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 6, 2017
Pembrolizumab for advanced melanoma: experience from the Spanish Expanded Access ProgramM González-Cao, A Arance, J M Piulats, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 3, 2024
Efficacy and safety of cemiplimab in the treatment of advanced cutaneous squamous cell carcinoma: A multicentre real-world retrospective study from Spain and systematic review of the published dataJ Cañueto, E Muñoz-Couselo, C Cardona-Machado, et al.
Atencion Primaria|October 9, 2007
[Pilot study for the inclusion of the portfolio of the family medicine specialist book in training]Roger Ruiz Moral, C Aguado, M Amian, et al.
Cancer Treatment and Research Communications|April 15, 2025
Analysis of operability parameter changes in neoadjuvant treatment with chemotherapy and anti-PD-1/PD-L1M Sereno, A Collazo-Lorduy, Y Garitaonaindia, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 6, 2017
Pembrolizumab for advanced melanoma: experience from the Spanish Expanded Access ProgramM González-Cao, A Arance, J M Piulats, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 3, 2024
Efficacy and safety of cemiplimab in the treatment of advanced cutaneous squamous cell carcinoma: A multicentre real-world retrospective study from Spain and systematic review of the published dataJ Cañueto, E Muñoz-Couselo, C Cardona-Machado, et al.
Atencion Primaria|October 9, 2007
[Pilot study for the inclusion of the portfolio of the family medicine specialist book in training]Roger Ruiz Moral, C Aguado, M Amian, et al.
Cancer Treatment and Research Communications|April 15, 2025
Analysis of operability parameter changes in neoadjuvant treatment with chemotherapy and anti-PD-1/PD-L1M Sereno, A Collazo-Lorduy, Y Garitaonaindia, et al.
Pageof 6